H. Pylori (Helicobacter Pylori) Test Market Research Report - Forecast till 2030

H. Pylori (Helicobacter Pylori) Test Market Research Report: By Test Type (Non-Endoscopic, Endoscopic), By Technology (Immunoassays, Point-of-Care (POC), Molecular Diagnostics) and By End-User (Hospitals and Clinics, Diagnostics Laboratories, Others) – Forecast to 2030

ID: MRFR/HC/7025-HCR | 90 Pages | Published By Kinjoll Dey on April 2023         

Helicobacter Pylori Test Market Speak to Analyst Request a Free Sample

Market Overview

The H. Pylori Test Market is evaluated to have significant growth at 5.70%. Furthermore, the market value is expected to increase up to USD 3,864.04 Million in the forecast period 2030. The H. Pylori stands for Helicobacter Pylori which is an aerobic bacterium having a spiral shape. It is mainly found in the stomach. H. Pylori disease leads to a stomach infection and is commonly found in both women and men. This disease causes gastritis and stomach ulcers and further leads to duodenal ulcers.

This disease infects around 50% population across the world. Therefore, the H. Pylori Test Market is expected to witness significant growth. According to the H. Pylori Test Market Analysis, the Americas hold the largest share. Also, the growing development and awareness will further promote market growth.

COVID-19 Analysis

The COVID-19 disease leads to a negative effect on the H. Pylori Test Market. The increasing demand for COVID-19 testing negatively impacted the testing of other diseases. Initially, the mortality rate of the coronavirus was high and it halted the treatment of patients suffering from other diseases. Apart from that, a huge problem occurred for product distribution due to distribution in the supply chain and border lockdowns. Overall, coronavirus disease highly impacted the key players and the economy of various governments.

Market Dynamics

Market Drivers

The various drivers pushing the H. Pylori Test Market are increasing cases and awareness about H. Pylori disease. Also, the increasing population of the older generation is anticipated to fuel market growth.


The low tests conducted for the diagnosis of H. Pylori disease is crucial restraint for the market growth.


There are many opportunities such as investments by key players are anticipated to elevate the market growth. Along with that, other strategic steps such as market analysis, mergers, partnerships, collaboration, etc. will improve the chances of new opportunities for the market.


The economic disruptions caused by the coronavirus and low awareness can be challenging for market growth. Also, the low awareness and lack of skilled professionals across the world can hamper the H. Pylori Test Market Growth.

Cumulative Analysis

The Compound Annual Growth Rate of the H. Pylori Test Market is evaluated to reach up to 5.70%. Furthermore, the H. Pylori Test Market Value is expected to reach around USD 3,864.04 Million in the studied forecast period 2022-2030. Rapid development, support from the governments, and the increasing geriatric population are the important drivers of the market. However, the number of tests for diagnosis of H. Pylori is low which can hinder the market growth. Therefore, the market is anticipated to witness substantial growth.  

Value Chain Analysis

The increasing H. Pylori Test Market Trends due to the growing awareness and rising cases of H. Pylori diseases will simultaneously improve the market growth. Along with that, the developments by key players and support from the governments to improve the healthcare sector will further improve the value chain of the market.

Market Segmentations

The H. Pylori Test Market Size is segmented into technology, test type, and end-user. On the basis of technology, the market is divided into Point of Care (PoC), Immunoassays, and Molecular Diagnostics. In 2018, the immunoassays segment achieved the highest growth as it was used for detecting antibodies. Also, Point of Care is a non-invasive test that includes a C-urea breath test, monoclonal stool antigen, and IgG serology. Furthermore, Molecular diagnostic helps to identify H. Pylori in areas around the stomach.

On the basis of test type, the H. Pylori Test Market is bifurcated into Endoscopic and Non-Endoscopic. The endoscopic segment is further categorized into Histology, Culture, Polymerase Chain Reaction, and Campylobacter-like Organism (CLO)/Rapid Urease Test. The non-endoscopic segment is divided into Urea Breathe Test and the Faecal/Stool Antigen Test (SAT).  

On the basis of end-user, the H. Pylori Test Market is fragmented into Clinics and Hospitals, Diagnostic Laboratories, and others. The clinics and hospitals segment has observed a significant rise mainly in companies such as India and China. As a result, the H. pylori test simultaneously increased. However, the diagnostic laboratories are anticipated to witness the fastest market growth in the studied forecast period. The others segment comprises ambulatory centers, etc.

Regional Analysis

Based on region, the H. Pylori Test Market is divided into Europe, the Americas, Asia-Pacific, Africa, and the Middle East. It is anticipated that the Americas will hold the largest share in the market. Several positive factors such as the presence of various key players and advanced healthcare infrastructure are anticipated to fuel the market growth.

However, Europe is evaluated to hold the second-largest H. Pylori Test Market Share. The high consumption of various antibiotics in many countries is an important factor. Also, the rising investments and presence of various key players are evaluated to boost the market growth.

Thirdly, the Asia-Pacific region is evaluated to experience the fastest growth. Due to the presence of the affected population, the region will have significant growth. Also, the poor sanitization among several countries will lead to the increase of H. Pylori disease.

Africa and the Middle East region will have the least share in the market. However, this region is expected to have significant growth. The increasing cases of H. Pylori in countries such as Saudi Arabia, Oman, and the market will grow rapidly.

Competitive Landscape

The H. Pylori Test Market has the immense presence of various key players. Some important key players in the market are as follows.

  • Biohit Oyj (Finland)

  • Bio-Rad Laboratories, Inc. (US)

  • Quest Diagnostics Incorporated (US)

  • Cardinal Health (US)

  • Abbott Laboratories (US)

  • Thermo Fisher Scientific Inc. (US)

  • QIAGEN (Germany)

  • Meridian Bioscience (US)

  • Hoffman La-Roche Ltd. (Switzerland)

  • CorisBioconcept SPRL (Belgium)

  • Meridian Bioscience (US)

Recent Developments

No Recent Developments Found

Report Overview

The overview of the H. Pylori Test Market Outlook is as follows.

  • Market Overview

  • COVID-19 Analysis

  • Dynamics of the Market

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Development

Report Score and Segmentation

The report score is to provide substantial information about H. Pylori Test Market Forecast. The report covers important information such as CAGR, market value, drivers, challenges, and many more. The information highlighted in this report is gathered from various secondary and primary sources.

  • Study Period- 2021-2028

  • Base Year-2021

  • Forecast Period- 2021-2028

  • Historical Period-2017-2020


  • By Technology

  • Point of Care

  • C-Urea Breath Test

  • Monoclonal Stool Antigen

  • IgG Serology

  • Immunoassays


  • By Type

  • Endoscopic

  • Histology

  • Culture

  • Polymerase Chain reaction

  • Culture

  • Campylobacter-like Organism/Rapid Increase

  • Non-Endoscopic

  • Stool Antigen Test

  • Serology Antibody Test

  • Urea Breath Test


  • By End-User

  • Clinics and Hospitals

  • Diagnostic Laboratories

  • Others


  • By Region

  • Europe

  • Americas

  • Africa and the Middle East

  • Asia-Pacific

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

H. Pylori (helicobacter pylori) test market is projected grow at approximately 5.70% CAGR during the assessment period (2020-2030).

The valuation of the global H. Pylori (helicobacter pylori) test market is estimated to increase to USD 3,864.04 MN by the end of 2030.

The non-endoscopic segment by type holds the majority shares in the global H. Pylori (helicobacter pylori) test market.

North America holds the largest share in the global H. Pylori (helicobacter pylori) test market, followed by Europe and the Asia Pacific, respectively.

Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Quest Diagnostics Incorporated (US), Meridian Bioscience (US), F. Hoffmann-La Roche Ltd (Switzerland), CorisBioconcept SPRL (Belgium), Abbott Laboratories (US), Biohit Oyj (Finland), and Cardinal Health (US), QIAGEN (Germany), are some of the major players operating in the global H. Pylori (helicobacter pylori) test market.